Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to verify the clinical efficacy and safety of different statins in
dyslipidemia patients, and explore the effects on glycometabolic in patients with impaired
glucose regulation.
Phase:
Phase 4
Details
Lead Sponsor:
Fudan University
Collaborators:
Jiangsu Wanbang Medicine Marketing Co., Ltd. Peking University People's Hospital